Current Data from the first Head-to-Head Study on Biologic Therapy in Ulcerative Colitis Patients Clinical Remission and Mucosal Healing in Adults: Vedolizumab superior to Adalimumab

被引:0
|
作者
Thaesler, Elke
机构
关键词
MAINTENANCE THERAPY; INDUCTION; DISEASE;
D O I
10.1159/000502370
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:275 / 275
页数:1
相关论文
共 50 条
  • [21] Switching from intravenous to subcutaneous VEDOlizumab formulation in ulcerative colitis patients in clinical remission: the SVEDO Study, a multicenter IG-IBD study
    Ribaldone, D. G.
    Parisio, L.
    Variola, A.
    Bossa, F.
    Castiglione, F.
    Marzo, M.
    Piazza, N.
    Aratari, A.
    Savarino, E. V.
    Bodini, G.
    Mastronardi, M.
    Micheli, F.
    Mazzuoli, S.
    Ascolani, M.
    Vigano, C.
    Cappello, M.
    Bezzio, C.
    Ciccocioppo, R.
    Scardino, G.
    Sarli, E.
    Pugliese, D.
    Scaldaferri, F.
    Napolitano, D.
    Todeschini, A.
    Geccherle, A.
    Colaci, N.
    Guerra, M.
    Annese, M.
    Testa, A.
    Caiazzo, A.
    Conforti, F. S.
    Festa, S.
    Lorenzon, G.
    Marra, A.
    Magiotta, A.
    Baccini, F.
    Amato, A.
    Vernero, M.
    Caprioli, F.
    Caviglia, G. P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1176 - I1176
  • [22] Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study
    Sandborn, W. J.
    Schreiber, S.
    Lee, S. D.
    Lindsay, J. O.
    Hebuterne, X.
    Zhou, W.
    Cataldi, F.
    Lacerda, A. P.
    Huang, B.
    Xie, W.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S9 - S9
  • [23] Letter to the Editor: Switching from vedolizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study
    Rajab, Fatima
    Mujahid, Aleena
    Rajab, Hadia
    Alvi, Abdullah
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (04) : 716 - 717
  • [24] Clinical predictors of endoscopic mucosal healing in patients with quiescent ulcerative colitis: data from Nixon-TAM HK IBD Registry
    Shi, Hai Yun
    Chan, K. L. Francis
    Ching, Jessica
    Chung, Tiffany
    Lo, Fu Hang
    Tsang, Steven
    Sze, S. F. Alex
    Hui, Yee Tak
    Shan, H. S. Edwin
    Li, K. K. Michael
    Ng, Siew C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 27 - 27
  • [25] IMPROVED ENDOSCOPIC OUTCOMES AND MUCOSAL HEALING OF UPADACITINIB AS AN INDUCTION THERAPY IN ADULTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE U-ACHIEVE STUDY
    Sandborn, William J.
    Schreiber, Stefan
    Lee, Scott D.
    Lindsay, James O.
    Hebuterne, Xavier
    Zhou, Wen
    Cataldi, Fabio
    Lacerda, Ana P.
    Huang, Bidan
    Xie, Wangang
    Loftus, Edward V.
    GASTROENTEROLOGY, 2019, 156 (06) : S170 - S171
  • [26] A HEAD-TO-HEAD COMPARISON OF IXEKIZUMAB AND ADALIMUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK EFFICACY AND SAFETY OUTCOMES FROM A RANDOMIZED, OPEN-LABEL, BLINDED ASSESSOR STUDY
    Smolen, Josef
    Nash, Peter
    Tahir, Hasan
    Schulze-Koops, Hendrik
    Li, Lingnan
    Hojnik, Maja
    Gellett, Amanda M.
    Leage, Soyi Liu
    Pillai, Sreekumar G.
    Mease, Philip
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 17 - 17
  • [27] A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naive Patients with Active Psoriatic Arthritis: Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor Study Through 52 Weeks
    Smolen, Josef
    Nash, Peter
    Tahir, Hasan
    Schulze-Koops, Hendrik
    Li, Lingnan
    Hojnik, Maja
    Gellett, Amanda
    Liu-Leage, Soyi
    Pillai, Sreekumar
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] A HEAD-TO-HEAD COMPARISON OF IXEKIZUMAB AND ADALIMUMAB IN BIOLOGIC-NAiVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK EFFICACY AND SAFETY OUTCOMES FROM A RANDOMIZED, OPEN-LABEL, BLINDED ASSESSOR STUDY
    Chaudhury, Sukanya
    Gellett, Amanda M.
    Hojnik, Maja
    Leage, Soyi Liu
    Li, Lingnan
    Mease, Philip
    Nash, Peter
    Pillai, Sreekumar G.
    Schulze-Koops, Hendrik
    Smolen, Josef
    Tahir, Hasan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 125 - 125
  • [29] A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naive Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor study
    Smolen, Josef
    Nash, Peter
    Tahir, Hasan
    Schulze-Koops, Hendrik
    Li, Lingnan
    Hojnik, Maja
    Gellett, Amanda
    Liu-Leage, Soyi
    Pillai, Sreekumar
    Mease, Philip
    Bessette, Louis
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1042 - 1042
  • [30] Mucosal Healing, Depression and Stress Did Not Predict Relapse of Ulcerative Colitis Patients in Clinical Remission Not on Immunosuppressive Drugs: A Prospective 12-Months Follow-up Study
    Langhorst, Jost
    Hofstetter, Anna
    Wolfe, Frederick
    Haeuser, Winfried
    GASTROENTEROLOGY, 2013, 144 (05) : S640 - S640